LFST Relative Valuation
LFST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LFST is overvalued; if below, it's undervalued.
Historical Valuation
LifeStance Health Group Inc (LFST) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.96. The fair price of LifeStance Health Group Inc (LFST) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：6.46
Fair
221.99
PE
1Y
3Y
5Y
Trailing
Forward
16.07
EV/EBITDA
LifeStance Health Group Inc. (LFST) has a current EV/EBITDA of 16.07. The 5-year average EV/EBITDA is 45.10. The thresholds are as follows: Strongly Undervalued below -21.78, Undervalued between -21.78 and 11.66, Fairly Valued between 78.54 and 11.66, Overvalued between 78.54 and 111.98, and Strongly Overvalued above 111.98. The current Forward EV/EBITDA of 16.07 falls within the Historic Trend Line -Fairly Valued range.
125.49
EV/EBIT
LifeStance Health Group Inc. (LFST) has a current EV/EBIT of 125.49. The 5-year average EV/EBIT is -28.07. The thresholds are as follows: Strongly Undervalued below -250.98, Undervalued between -250.98 and -139.52, Fairly Valued between 83.39 and -139.52, Overvalued between 83.39 and 194.85, and Strongly Overvalued above 194.85. The current Forward EV/EBIT of 125.49 falls within the Overvalued range.
1.58
PS
LifeStance Health Group Inc. (LFST) has a current PS of 1.58. The 5-year average PS is 2.95. The thresholds are as follows: Strongly Undervalued below -1.55, Undervalued between -1.55 and 0.70, Fairly Valued between 5.20 and 0.70, Overvalued between 5.20 and 7.45, and Strongly Overvalued above 7.45. The current Forward PS of 1.58 falls within the Historic Trend Line -Fairly Valued range.
17.44
P/OCF
LifeStance Health Group Inc. (LFST) has a current P/OCF of 17.44. The 5-year average P/OCF is 50.25. The thresholds are as follows: Strongly Undervalued below -33.98, Undervalued between -33.98 and 8.14, Fairly Valued between 92.37 and 8.14, Overvalued between 92.37 and 134.48, and Strongly Overvalued above 134.48. The current Forward P/OCF of 17.44 falls within the Historic Trend Line -Fairly Valued range.
22.43
P/FCF
LifeStance Health Group Inc. (LFST) has a current P/FCF of 22.43. The 5-year average P/FCF is -263.72. The thresholds are as follows: Strongly Undervalued below -2964.99, Undervalued between -2964.99 and -1614.35, Fairly Valued between 1086.92 and -1614.35, Overvalued between 1086.92 and 2437.56, and Strongly Overvalued above 2437.56. The current Forward P/FCF of 22.43 falls within the Historic Trend Line -Fairly Valued range.
LifeStance Health Group Inc (LFST) has a current Price-to-Book (P/B) ratio of 1.68. Compared to its 3-year average P/B ratio of 1.70 , the current P/B ratio is approximately -1.05% higher. Relative to its 5-year average P/B ratio of 2.28, the current P/B ratio is about -26.23% higher. LifeStance Health Group Inc (LFST) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.49%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -0.50% , the current FCF yield is about -100.00% lower.
1.68
P/B
Median3y
1.70
Median5y
2.28
4.80
FCF Yield
Median3y
0.49
Median5y
-0.50
Competitors Valuation Multiple
The average P/S ratio for LFST's competitors is , providing a benchmark for relative valuation. LifeStance Health Group Inc Corp (LFST) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 16.34%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of LFST decreased by 12.35% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -109.98 to -205.77.
The secondary factor is the Revenue Growth, contributed 16.34%to the performance.
Overall, the performance of LFST in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is LifeStance Health Group Inc (LFST) currently overvalued or undervalued?
What is LifeStance Health Group Inc (LFST) fair value?
How does LFST's valuation metrics compare to the industry average?
What is the current P/B ratio for LifeStance Health Group Inc (LFST) as of Dec 05 2025?
What is the current FCF Yield for LifeStance Health Group Inc (LFST) as of Dec 05 2025?
What is the current Forward P/E ratio for LifeStance Health Group Inc (LFST) as of Dec 05 2025?